Skip to main content

CDKL5 Deficiency Disorder clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • A Study of Soticlestat in Adults and Children With Rare Epilepsies

    Sorry, in progress, not accepting new patients

    The main aim is to assess the long-term safety and tolerability of soticlestat when used along with other anti-seizure treatment. Participants will receive soticlestat twice a day. Participants will visit the study clinic every 2-6 months throughout the study. Study treatments may continue as long as the participant is receiving benefit from it.

    at UCLA